Sorry, you need to enable JavaScript to visit this website.
  • Branded drugs are more expensive because they’re newer, generally groundbreaking, and often for conditions that are difficult to treat. However, after a certain period of time, these same innovative medicines become generic medicines.

  • The difference between our approach and that of many other companies is that when a medicine becomes a generic, we still assume responsibility. Rather than focus on just what’s in development, we continue to closely monitor the quality, safety, and reliability of our generic medicines.

Programs & Initiatives This Rotational R&D Program Allows Young Scientists to Experiment in Their Careers Participants in Pfizer's unique science career program can gain experience in drug discovery, regulatory affairs & more. Purpose & Ideals An Accord for a Healthier World: Working Together to Help Address Unmet Healthcare Needs in Lower-Income Countries In 2022, Pfizer launched An Accord for a Healthier World to improve access to healthcare by providing medicines and vaccines to 45 lower-income countries. Science & Innovation In Celebrating 175 Years, Pfizer Challenges Itself to ‘Outdo Yesterday’ It started with a breakthrough. And still, this is just the beginning. Looking ahead to the next 175 years, Pfizer’s motivation, today, isn’t to stay the course—it’s to outdo yesterday.

The medicines available today have taken an average of 12 years to develop. With dedication, creativity, and science, we can significantly cut that time.

Learn more about the process of joining a clinical trial and find a trial near you.

Go to Pfizer Clinical Trials Site